Locations
Nova Scotia, Canada · Halifax, NS, Canada · Halifax, NS, Canada · Halifax Regional Municipality, NS, Canada
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series C+
founded in
2012
ABK Biomedical is a clinical-stage medical device company focused on researching, developing, and commercializing innovative therapies for treating liver tumors. Their key products include Eye90 microspheres®, which utilize a proprietary imageable glass composition for Y90 radioembolization, and Easi-Vue™ embolic microspheres for direct visualization during embolization procedures. The company differentiates itself through its advanced technology and commitment to improving patient outcomes, having raised significant funding and achieved FDA designations for its products. With a strong leadership team and a focus on R&D, ABK Biomedical is well-positioned in the oncology market.
Something looks off?